Bristol-Myers retirees just won a round in court fighting the handoff of their $2 billion pension to an insurer

Leisure of pensioners

Thousands of Bristol-Myers Squibb retirees cleared a procedural hurdle in their legal fight against the company’s decision to shift roughly $2 billion in pension obligations to an insurance company. The ruling allows the case to move forward on claims that the 2019 transfer exposed retirees to weaker financial protections than they had under the drugmaker’s own pension plan. For former employees whose retirement income now depends on an insurer’s balance sheet rather than a Fortune 500 corporation’s, the stakes are direct and personal.

What the Athene Pension Transfer Means for Retirees

The core tension is straightforward. Bristol-Myers Squibb used plan assets to purchase annuity contracts from Athene Annuity and Life Company and Athene Annuity & Life Assurance Company of New York on Aug. 2, 2019. That transaction converted pension promises backed by a major pharmaceutical company into annuity obligations held by an insurer. The company described the step as part of a broader effort to transfer billions of dollars in U.S. pension liabilities, a strategy it highlighted in a corporate announcement aimed at investors and the market.

Retirees argue that the switch changed who stands behind their monthly checks and, by extension, the quality of the guarantee. A corporate pension plan carries federal protections under ERISA and is backstopped by the Pension Benefit Guaranty Corporation, which insures defined-benefit plans up to statutory limits if a sponsor fails. An annuity contract, by contrast, is regulated at the state level and depends on the insurer’s reserves, investment practices, and the relevant state guaranty association, each of which can vary by jurisdiction and is typically subject to caps.

The difference is not academic. If the insurer were to face financial distress, retirees could find themselves in a weaker position than they would have been under the original plan, particularly if their promised benefits exceed state guaranty limits or if a rehabilitation process delays payments. Plaintiffs in the Bristol-Myers Squibb case contend that this shift in risk profile was imposed on them without meaningful choice, even though the value of their earned benefits was significant and central to their retirement planning.

The court’s decision to let the case proceed does not reverse the Athene contracts or restore the prior pension structure. It does, however, keep the door open for discovery and potential rulings on whether Bristol-Myers Squibb followed proper procedures and met its fiduciary duties when it handed off the obligations. The litigation will likely probe what information was provided to participants, what alternatives were considered, and how the company evaluated insurers and contract terms before executing the transfer.

For now, the more likely near-term effect is pressure on how companies disclose and justify pension-risk transfers, not an unwinding of deals already executed. Employers watching the case may revisit internal documentation standards, communication strategies with retirees, and the criteria they use when selecting insurers for similar transactions. Even without a final judgment, a detailed factual record could shape industry norms and influence how regulators and policymakers view large-scale pension de-risking.

SEC Filings and the $3.8 Billion Transfer Trail

The factual record behind this dispute is anchored in corporate filings and public announcements. Bristol-Myers Squibb’s SEC exhibit details the mechanics: plan assets were used to buy group annuity contracts, and benefits became payable under those contracts rather than directly from the pension trust. The filing identifies the Athene entities involved in the transaction, describes the nature of the obligations they assumed, and fixes the effective date at Aug. 2, 2019, providing a clear timeline for when retirees’ benefit backing changed.

The company’s own press materials framed the move as a transfer of approximately $3.8 billion in U.S. pension liabilities, a figure that covers more than just the roughly $2 billion at issue in the litigation. That gap suggests the transfer was executed in stages or across multiple groups of beneficiaries, potentially separating certain retiree cohorts or benefit formulas, though the available record does not break down the allocation in detail. Without a public schedule of which participant groups were included in each tranche, affected retirees and outside observers must infer the scope from aggregate numbers.

What the filings do not contain is equally telling. There is no public disclosure from Athene or Bristol-Myers Squibb addressing post-transfer claim experience specific to this retiree block, the level of reserves earmarked solely for these obligations, or any independent assessment of whether retirees’ benefits are as secure under the new arrangement as they were before. The documents describe the legal structure of the transaction but stop short of offering a comparative risk analysis from the participant’s perspective.

That absence of granular information lies at the heart of the retirees’ concerns. Many participants learned that their benefits had been moved only after the fact, through notices that explained the new annuity provider but did not necessarily spell out how state-based protections differ from federal pension insurance. For individuals who had long assumed their checks were backed by a large corporate sponsor and a federal guarantor, the shift to an insurer-centered framework can feel like a material change in the safety net, even if the nominal benefit amount remains the same.

As the case moves forward, the court will have to balance employers’ interest in managing balance-sheet risk against retirees’ expectation that pension promises will not be weakened through complex financial transactions. Whatever the outcome, the Bristol-Myers Squibb dispute underscores a broader reality: in an era of widespread pension de-risking, the fine print of annuity transfers can be just as important to retirement security as the size of the monthly benefit itself.


Free tool for readers: Most people don’t find out they’re off track until it’s too late. You can see where your retirement stands with a free Retirement Safety Score in about five minutes — no sign-up required to see it.

Leave a Reply

Your email address will not be published. Required fields are marked *